The Algorithmic Consultant: Why Every AI-Native Health Company Needs Validation Led by a Physician

Healthcare AI is having a moment. Ambient scribes are everywhere, decision-support tools ship weekly, and venture money flows toward anything with "agentic" in the pitch deck. But there's a quieter statistic that should give every operator pause: roughly 95% of generative AI initiatives never make it past pilot. ¹ In healthcare, the failure mode is rarely the model itself. It's what happens between the model's output and a clinician's decision.

That gap is where companies either earn trust or lose it permanently. And it's the exact gap a recent paper in npj Digital Medicine names with welcome precision: the algorithmic consultant. ²

Marwaha and colleagues propose a new clinical role of a physician with both algorithmic fluency and clinical judgment. This role is modeled after how clinical pharmacists govern a hospital's formulary and consult on individual prescribing decisions. We don't expect every physician to memorize the pharmacokinetics of every drug; we expect the system to include specialists who do. AI in clinical workflows demands the same architecture. Static disclosures and explainability dashboards just aren't enough. The authors note that direct interactions between physician and AI often fail to improve decisions because those resources are static and can't adapt to the nuance of an actual clinical scenario. ²

If this sounds abstract, the cautionary tales aren't. When Epic's widely deployed sepsis prediction model was studied, it performed substantially worse than its developer reported, missing the majority of sepsis cases and generating significant alert fatigue along the way.³ A widely used commercial algorithm allocating care management resources systematically underestimated illness severity in Black patients because health spending was used as a proxy for medical need.⁴ Neither was a coding error. Both were clinical reasoning error the kind a physician embedded early in development would have flagged in an afternoon.

So, what does physician-led validation look like in practice? In my experience working at the intersection of clinical care, payer operations, and population health, it isn't a vague seal of approval. It's a structured practice with four concrete pieces.

First, it asks whether the clinical question the model answers is the right one. A model that predicts 30-day readmission is not the same as a model that predicts preventable readmission and confusing the two leads to interventions that don't move outcomes.

Second, it interrogates the training data for representativeness against the population the tool will serve. Models trained on academic medical center data behave differently in safety-net clinics, rural hospitals, and Medicaid populations. A physician with population health experience knows where those gaps live before deployment, not after.

Third, it stress-tests the workflow integration. Does the alert fire at a moment when the clinician can act on it? Does it create a documentation burden that quietly erodes the time savings it promised? The best model in the world is clinically useless if it surfaces the right answer at the wrong moment.

Fourth, it builds the ongoing governance layer. This is what the npj authors describe as overseeing "the hospital's ecosystem of algorithms" through their lifecycle. ² Models drift. Populations change. Thresholds need recalibration. Rather than a launch task, this should be a permanent operating function.

None of this is hypothetical. The FDA has now authorized more than a thousand AI/ML enabled medical devices, with evolving guidance that emphasizes real world performance monitoring and predetermined change control plans.⁵ The Coalition for Health AI has published assurance standards that explicitly call for clinical subject matter expertise across the model lifecycle.⁶ The American Medical Association's principles on augmented intelligence place physician oversight at the center of safe deployment.⁷ The regulatory and professional consensus has already arrived. The market is catching up.

So, what does this mean for AI-native health companies? Honestly, it's simple. A physician advisor on a slide deck or a part-time CMO reviewing outputs once a quarter is not validation. Validation is a repeatable, documented practice. Clinical questions should be vetted before model selection, with training data audited against the deployment population, and workflows tested with real end users. Companies that build this in early ship faster, fail less, and earn the trust that makes enterprise procurement possible. Companies that don't will keep landing in that 95%.

For physicians who want to contribute meaningfully to this work, the field is still defining itself, and the questions are perhaps the most interesting ones in medicine right now. The npj paper is an early but important attempt to give the role a name. Whether we ultimately call it the algorithmic consultant, the clinical AI advisor, or something else entirely a year from now, the one thing is clear: someone must stand between the model and the patient. And that someone must understand both well enough to push back, slow things down, and insist that a smart-looking output is actually the right output for this patient, in this workflow, on this day.

The companies that will define the next decade of clinical AI are the ones that figure this out before their first publicized failure — not after.

References

1. Challapally A, Pease C, Raskar R, Chari P. The GenAI divide: state of AI in business 2025. MIT NANDA Project; 2025.

2. Marwaha JS, Kennedy CJ, Chen JH, et al. The algorithmic consultant: a new era of clinical AI calls for a new workforce of physician-algorithm specialists. npj Digit Med. 2025;8:552.

3. Wong A, Otles E, Donnelly JP, et al. External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Intern Med. 2021;181(8):1065-1070.

4. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366(6464):447-453.

5. US Food and Drug Administration. Artificial intelligence and machine learning (AI/ML)-enabled medical devices. FDA; updated 2025. Accessed April 2026.

6. Coalition for Health AI. Assurance standards guide for the responsible use of AI in healthcare. CHAI; 2024.

7. American Medical Association. Principles for augmented intelligence development, deployment, and use. AMA; 2023.